Skip to main content
logo
TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.31
-0.07 (-0.67%)
Aug 21, 2026, 4:08 PM HKT

HKG:2617 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
---1.180.12
Revenue Growth
---852.42%-
Gross Profit
---1.180.12
Operating Income
-301.54-301.54-291.77-382.52-312.36
Net Income
-295.96-295.96-274.61-343.39-251.94
Earnings Per Share
-0.76-0.76-0.72-0.90-0.70
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
489.39489.39573.93838.72984.35
Total Debt
1.651.654.374.812.69
Net Cash (Debt)
487.74487.74569.56833.91981.66
Net Cash Growth
-23.12%-14.37%-31.70%-15.05%-
Net Cash Per Share
1.251.251.492.192.72

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-253.51-253.51-271.18-319.33-236.89
Capital Expenditures
-0.16-0.16-0.77-3.49-2.02
Free Cash Flow
-253.68-253.68-271.96-322.81-238.91
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
---100.00%100.00%
Operating Margin
----32389.58%-251900.00%
Pretax Margin
----29076.55%-203180.65%
Profit Margin
----29076.54%-203180.65%
FCF Margin
----27333.78%-192667.74%

Valuation
Selected indicators aren't available for this stock.